113 related articles for article (PubMed ID: 37759102)
1. TIMP1 is an early biomarker for detection and prognosis of lung cancer.
Dantas E; Murthy A; Ahmed T; Ahmed M; Ramsamooj S; Hurd MA; Lam T; Malbari M; Agrusa C; Elemento O; Zhang C; Pappin DJ; McGraw TE; Stiles BM; Altorki NK; Goncalves MD
Clin Transl Med; 2023 Oct; 13(10):e1391. PubMed ID: 37759102
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of TIMP-1 in non-small cell lung cancer.
Pesta M; Kulda V; Kucera R; Pesek M; Vrzalova J; Liska V; Pecen L; Treska V; Safranek J; Prazakova M; Vycital O; Bruha J; Holubec L; Topolcan O
Anticancer Res; 2011 Nov; 31(11):4031-8. PubMed ID: 22110238
[TBL] [Abstract][Full Text] [Related]
3. TIMP1 and adverse prognosis in non-small cell lung cancer.
Fong KM; Kida Y; Zimmerman PV; Smith PJ
Clin Cancer Res; 1996 Aug; 2(8):1369-72. PubMed ID: 9816309
[TBL] [Abstract][Full Text] [Related]
4. Secretory autophagy promotes Rab37-mediated exocytosis of tissue inhibitor of metalloproteinase 1.
Wu SY; Chen JW; Liu HY; Wang YC; Chu YS; Huang CY; Lan KY; Liu HS; Lan SH
J Biomed Sci; 2022 Dec; 29(1):103. PubMed ID: 36457117
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of measuring expression levels of KAP1, TIMP1 and STC2 in peripheral blood of patients with gastric cancer.
Wang YY; Li L; Zhao ZS; Wang HJ
World J Surg Oncol; 2013 Apr; 11():81. PubMed ID: 23548070
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of an ECM organization-related gene signature as a prognostic biomarker and therapeutic target for glioma patients.
Zhong Q; Zhong Q; Cai X; Wu R
Genes Genomics; 2023 Sep; 45(9):1211-1226. PubMed ID: 37301776
[TBL] [Abstract][Full Text] [Related]
7. A prospective cohort study of TIMP1 as prognostic biomarker in gastric and colon cancer.
Macedo FC; Cunha N; Pereira TC; Soares RF; Monteiro AR; Bonito N; Valido F; Sousa G
Chin Clin Oncol; 2022 Dec; 11(6):43. PubMed ID: 36509552
[TBL] [Abstract][Full Text] [Related]
8. Small GTPase Rab37 targets tissue inhibitor of metalloproteinase 1 for exocytosis and thus suppresses tumour metastasis.
Tsai CH; Cheng HC; Wang YS; Lin P; Jen J; Kuo IY; Chang YH; Liao PC; Chen RH; Yuan WC; Hsu HS; Yang MH; Hsu MT; Wu CY; Wang YC
Nat Commun; 2014 Sep; 5():4804. PubMed ID: 25183545
[TBL] [Abstract][Full Text] [Related]
9. Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.
Li BT; Lou E; Hsu M; Yu HA; Naidoo J; Zauderer MG; Sima C; Johnson ML; Daras M; DeAngelis LM; Fleisher M; Kris MG; Azzoli CG
PLoS One; 2016; 11(1):e0146063. PubMed ID: 26730601
[TBL] [Abstract][Full Text] [Related]
10. Association of Tissue Inhibitor of Metalloproteinase-1 Genotypes with Lung Cancer Risk in Taiwan.
Lai CY; Chang WS; Hsieh YH; Hsu CM; Tsai CW; Chen AC; Wang CH; Bau DT
Anticancer Res; 2016 Jan; 36(1):155-60. PubMed ID: 26722039
[TBL] [Abstract][Full Text] [Related]
11. The favorable prognostic impact of tissue inhibitor of matrix metalloproteinases-1 protein overexpression in breast cancer cells.
Nakopoulou L; Giannopoulou I; Lazaris ACh; Alexandrou P; Tsirmpa I; Markaki S; Panayotopoulou E; Keramopoulos A
APMIS; 2003 Nov; 111(11):1027-36. PubMed ID: 14629269
[TBL] [Abstract][Full Text] [Related]
12. VAMP8, a vesicle-SNARE required for RAB37-mediated exocytosis, possesses a tumor metastasis suppressor function.
Wang YS; Tzeng HT; Tsai CH; Cheng HC; Lai WW; Liu HS; Wang YC
Cancer Lett; 2018 Nov; 437():79-88. PubMed ID: 30165196
[TBL] [Abstract][Full Text] [Related]
13. TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic Cancer.
Schoeps B; Eckfeld C; Prokopchuk O; Böttcher J; Häußler D; Steiger K; Demir IE; Knolle P; Soehnlein O; Jenne DE; Hermann CD; Krüger A
Cancer Res; 2021 Jul; 81(13):3568-3579. PubMed ID: 33941611
[TBL] [Abstract][Full Text] [Related]
14. Concentrations of TIMP1 mRNA splice variants and TIMP-1 protein are differentially associated with prognosis in primary breast cancer.
Sieuwerts AM; Usher PA; Meijer-van Gelder ME; Timmermans M; Martens JW; Brünner N; Klijn JG; Offenberg H; Foekens JA
Clin Chem; 2007 Jul; 53(7):1280-8. PubMed ID: 17478562
[TBL] [Abstract][Full Text] [Related]
15. [Gene expression of MMP1 and TIMP1 in lung cancer detected with a cDNA microarray technique].
Ouyang QC; Hu CP; Liang QH
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):227-8. PubMed ID: 14653073
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
[TBL] [Abstract][Full Text] [Related]
17. [Expression of MMP1 and TIMP1 proteins in lung cancer and its biological significance].
Peng ZM; Yang ZL; Liu YW
Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):159-61. PubMed ID: 12575349
[TBL] [Abstract][Full Text] [Related]
18. Plasma TIMP1 level is a prognostic factor in patients with liver metastases.
Bunatova K; Pesta M; Kulda V; Topolcan O; Vrzalova J; Sutnar A; Treska V; Pecen L; Liska V
Anticancer Res; 2012 Oct; 32(10):4601-6. PubMed ID: 23060593
[TBL] [Abstract][Full Text] [Related]
19. TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway.
Song G; Xu S; Zhang H; Wang Y; Xiao C; Jiang T; Wu L; Zhang T; Sun X; Zhong L; Zhou C; Wang Z; Peng Z; Chen J; Wang X
J Exp Clin Cancer Res; 2016 Sep; 35(1):148. PubMed ID: 27644693
[TBL] [Abstract][Full Text] [Related]
20. Role of stemness-related genes TIMP1, PGF, and SNAI1 in the prognosis of colorectal cancer through single-cell RNA-seq.
Shen Y; Ni S; Li S; Lv B
Cancer Med; 2023 May; 12(10):11611-11623. PubMed ID: 37017587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]